KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $48,696,000 | +5.6% | 3,825,256 | +17.4% | 1.85% | -10.5% |
| Q4 2014 | $46,092,000 | -7.3% | 3,257,358 | -9.9% | 2.07% | -1.2% |
| Q3 2014 | $49,708,000 | -13.6% | 3,615,126 | -3.4% | 2.09% | -14.2% |
| Q2 2014 | $57,547,000 | -4.5% | 3,741,656 | +5.8% | 2.44% | -1.7% |
| Q1 2014 | $60,281,000 | +68.7% | 3,537,590 | +28.2% | 2.48% | +60.9% |
| Q4 2013 | $35,728,000 | – | 2,758,950 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |